"Middle Aged" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
No definition found.
Descriptor ID |
D008875
|
MeSH Number(s) |
M01.060.116.630
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Middle Aged".
Below are MeSH descriptors whose meaning is more specific than "Middle Aged".
This graph shows the total number of publications written about "Middle Aged" by people in this website by year, and whether "Middle Aged" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 171 | 171 |
1995 | 0 | 223 | 223 |
1996 | 0 | 237 | 237 |
1997 | 0 | 241 | 241 |
1998 | 0 | 276 | 276 |
1999 | 0 | 250 | 250 |
2000 | 0 | 328 | 328 |
2001 | 0 | 307 | 307 |
2002 | 0 | 342 | 342 |
2003 | 0 | 392 | 392 |
2004 | 0 | 389 | 389 |
2005 | 0 | 481 | 481 |
2006 | 0 | 567 | 567 |
2007 | 0 | 555 | 555 |
2008 | 0 | 673 | 673 |
2009 | 0 | 608 | 608 |
2010 | 0 | 679 | 679 |
2011 | 0 | 774 | 774 |
2012 | 0 | 782 | 782 |
2013 | 0 | 814 | 814 |
2014 | 0 | 808 | 808 |
2015 | 0 | 865 | 865 |
2016 | 0 | 897 | 897 |
2017 | 0 | 895 | 895 |
2018 | 0 | 963 | 963 |
2019 | 0 | 1014 | 1014 |
2020 | 0 | 842 | 842 |
2021 | 0 | 645 | 645 |
2022 | 0 | 145 | 145 |
2023 | 0 | 172 | 172 |
2024 | 0 | 33 | 33 |
To return to the timeline,
click here.
Below are the most recent publications written about "Middle Aged" by people in Profiles.
-
Association of Coronary Wall Thickening and Diminished Diastolic Function in Asymptomatic, Low Cardiovascular Disease-Risk Persons Living with HIV. Radiol Cardiothorac Imaging. 2024 Apr; 6(2):e230102.
-
SGLT2 Inhibitors, Functional Capacity, and Quality of Life in Patients With Heart Failure: A Systematic Review and Meta-Analysis. JAMA Netw Open. 2024 Apr 01; 7(4):e245135.
-
Finerenone cardiovascular and kidney outcomes by age and sex: FIDELITY post hoc analysis of two phase 3, multicentre, double-blind trials. BMJ Open. 2024 Mar 19; 14(3):e076444.
-
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial. Lancet. 2024 Mar 23; 403(10432):1153-1163.
-
RNA Interference With Zilebesiran for Mild to Moderate Hypertension: The KARDIA-1 Randomized Clinical Trial. JAMA. 2024 03 05; 331(9):740-749.
-
The Association Between Metformin Use and New-Onset ICD Coding of Geographic Atrophy. Invest Ophthalmol Vis Sci. 2024 Mar 05; 65(3):23.
-
Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor-Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination: A Phase 3 Randomized Clinical Trial. JAMA Oncol. 2024 Mar 01; 10(3):362-371.
-
Silymarin (Milk Thistle) Treatment of Adults With Gambling Disorder: A Double-Blind, Placebo-Controlled Trial. Clin Neuropharmacol. 2024 Mar-Apr 01; 47(2):54-58.
-
Home Oxygen After Hospitalization for COVID-19: Results From the Multi-Center OXFORD Study. Respir Care. 2024 Feb 28; 69(3):281-289.
-
Remote Dielectric Sensing Before and After Discharge in Patients With ADHF: The ReDS-SAFE HF Trial. JACC Heart Fail. 2024 Apr; 12(4):695-706.